Antivirals

Stability Hygroscopic Applications Isotope labelled Tenofovir Disoproxil Fumarate, an acyclic phosphonate nucleotide analogue; reverse transcriptase inhibitor. Used as an anti-HIV agent. Antiviral. References Shaw, J.-P., et al.: Pharm. Res., 14, 1824 (1997), Wyles, D., et al.: Clin Infect. Dis., 40, 174 (2005), Peng, J., et al.: J. Clin. Pharmacol., 46, 265 (2006), Seminari, E., et al.: J. Antimicrob. Chemother., 60, 831 (2007),

Stability Hygroscopic Applications O-Desethyl Resiquimod-d6 is the labelled analogue of O-Desethyl Resiquimod (D228575), which is derived from its parent compound Resiquimod (R144680), which is an imidazoquinoline derivative that acts as an immune response modifier. Resiquimod shows antitumor and antiviral activity and is used in the treatment of skin lesions such as herpes simplex virus. Resiquimod is a toll-like receptor 9 (TLR7) agonist. References Wu, J.J. et al.: Antivir. Res., 64, 79 (2004); Fife, K.H. et al.: Antimicrob. Agents Chemother., 52, 477 (2008); Szeimies, R.M. et al.: Brit. J. Dermatol., 159, 205 (2008);

Raltegravir is an antiretroviral agent, which is a synthetic integrase inhibitor sourced from pharmaceutical research. Its mode of action involves the inhibition of the HIV-1 integrase enzyme, which is essential for the viral replication process. By blocking the strand transfer step of the integration of viral DNA into the host cell genome, Raltegravir prevents the proliferation of the virus within the host. The primary use of Raltegravir is in the treatment of HIV-1 infection in combination with other antiretroviral agents. It is an integral part of highly active antiretroviral therapy (HAART) and is crucial for the management of patients who require a potent antiretroviral response, particularly in cases where resistance to other treatments may be a concern. Raltegravir is also utilized in both initial treatment settings and for patients who have experienced therapeutic failures with other regimens. Its efficacy and safety profile make it a critical component in the ongoing battle against HIV/AIDS, offering hope for improved patient outcomes and quality of life.

Sofosbuvir is an antiviral agent that is used for the treatment of hepatitis C infections and is used in combination with other antiviral agents. This drug is an inhibitor of viral RNA polymerase called non-structural protein 5B (NS5B). As a result, it inhibits viral RNA replication. Sofosbuvir is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready-to-use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.

Antiviral; Hepatitis C virus NS5A antagonist

Penciclovir is an antiviral agent and acyclic guanine derivative that has proven efficient in the treatment of Herpes Simplex type 1 and 2 (HSV1 and HSV2) infection. Penciclovir is transformed by the virus into an active derivative able to block the deoxyguanosine triphosphate substrate binding site of the HSV polymerase. Penciclovir is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready-to-use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.

AKOS B018304 is an arylalkylidene derivative with polar substitution at para-position.

BF738735 is a selective inhibitor of phosphatidylinositol 4-kinase III beta (PI4KIIIβ, IC50 = 5.7 nM) showing higher activity over α(IC50 = 1.7 μM).

(+)-Usnic acid (D-Usnic Acid) is a naturally occurring dibenzofuran derivative found in several lichen species.

Vidarabine phosphate is an adenosine monophosphate analog.

Applications MK 5172, also known as Grazoprevir, is a second-generation NS3/4A protease inhibitor that is often used in combination with the second-generation NS5A inhibitor, Elbasvir (E501010), for the treatment of hepatitis C virus infection. It is a COVID19-related research product. References Alric, L., et al.: Expert Opin. Pharmaco., 17, 735 (2016); Gentile, I., et al.: Expert Opin. Inv. Drug., 25, 557 (2016); Sulejmani, N., et al.: Expert Opin. Drug Met., 12, 353 (2016); Roensholt, F.F., et al.: Future Virol., 10, 691 (2015)

Applications 1,2-Dihydro-oseltamivir is the impurity of the anti-viral drug Oseltamivir Phosphate (O701000), which is an orally active inhibitor of influenza virus neuraminidase. It is a COVID19-related research product. References Oliyai, R., et al.: Pharm. Res., 15, 1300 (1998); Kim, C.U., et al.: Med. Chem. Res., 8, 392 (1998); Hayden, F.G., et al.: N. Engl. J. Med., 341, 1336 (1999); Treanor, J.J., et al.: J. Am. Med. Assoc., 283, 1016 (2000); Kalashnikov, A., et al.: Russ. Chem. Bull., 62, 163 (2013);